Systems and methods for the treatment of pain through neural fiber stimulation

Patent metadata

Field	Value
Publication number	US-11612746-B2
Application number	US-202016937680-A
Country	US
Kind code	B2
Filing date	Jul 24, 2020
Priority date	Nov 11, 2010
Publication date	Mar 28, 2023
Grant date	Mar 28, 2023

Abstract

Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.

First claim

Having thus described the invention, we claim:

1. A system to reduce a perception of pain, the system comprising:
a percutaneous lead;
a single contact electrode operatively coupled with the lead, the electrode percutaneously insertable into a patient; and
an electrical stimulator operatively coupled with the lead, the electrical stimulator electrically stimulating through the single contact electrode a plurality of target efferent motor nerve fibers to generate an action potential in the plurality of target efferent motor nerve fibers while avoiding generation of action potentials in small sensory nerve fibers.

2. The system of claim 1 , wherein the single contact electrode comprises an electrode contact surface area of between 0.001-200 mm 2 .

3. The system of claim 2 , wherein the electrode contact surface area is between 0.01-40 mm 2 .

4. The system of claim 2 , wherein the electrode contact surface area is between 0.1-20 mm 2 .

5. The system of claim 2 , wherein the electrode contact surface area is 200 mm 2 .

6. The system of claim 1 , wherein the electrical stimulator is configured to apply a stimulation intensity, wherein the stimulation intensity correlates with a shape, geometry, or surface area of the single contact electrode.

7. The system of claim 1 , wherein the electrical stimulator is an implantable electrical stimulator.

8. The system of claim 1 , wherein the electrical stimulator is an external electrical stimulator.

9. A method comprising:
percutaneously inserting a lead, the lead having an electrode;
positioning the electrode at a therapeutically effective distance from a target efferent nerve fiber; and
electrically stimulating through the electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a non-target nerve fiber.

10. The method of claim 9 , wherein the electrode is a single contact electrode.

11. The method of claim 9 , wherein the non-target nerve fiber comprises Type III and Type IV afferent nerve fibers.

12. The method of claim 9 , wherein the target efferent nerve fiber comprises a motor axon.

13. The method of claim 12 , wherein the motor axon comprises an Aα axon.

14. The method of claim 12 , wherein the motor axon comprises an Aγ axon.

15. The method of claim 12 , wherein the non-target nerve fiber includes at least one small sensory nerve fiber.

16. The method of claim 9 , further comprising:
removing the lead and electrode, wherein pain relief is generally maintained for a time after the removal.

17. The method of claim 9 , wherein the electrically stimulating generates or modulates response afferent activity by contracting muscle fibers to reduce pain in the patient.

18. A method comprising:
percutaneously inserting a single contact electrode in-vivo in a patient a therapeutically effective distance from a target efferent nerve fiber;
electrically stimulating through the single contact electrode the target efferent nerve fiber to generate an action potential in the target efferent nerve fiber while avoiding generation of action potentials in a small sensory neve fiber to generate or modulate response afferent activity by contracting muscle fibers to reduce pain in the patient.

19. The method of claim 18 , wherein the target efferent nerve fibers comprise motor axons.

20. The method of claim 18 further comprising activation of intrafusal or extrafusal muscle fibers.

Assignees

• Spr Therapeutics Inc

Inventors

• Bennett Maria E
• Boggs Joseph W
• Grill Warren M
• Chae John

Classifications

• A61N1/36071 Primary

  Pain · CPC title

• A61N1/36003

  of motor muscles, e.g. for walking assistance · CPC title

• A61N1/36057

  adapted for stimulating afferent nerves · CPC title

• A61N1/36017

  with leads or electrodes penetrating the skin · CPC title

• A61N1/36021

  for treatment of pain · CPC title